Review draws on experiences of patients and expert consensus
Primes company to submit vaccine candidate for rolling review
Drug is licensed for secondary progressive multiple sclerosis with active disease
DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy markets […]
Updated Date: Wed, 07 Oct 2020 00:00:00 EDT
Updated Date: Wed, 07 Oct 2020 00:00:00 EDT
Updated Date: Wed, 07 Oct 2020 00:00:00 EDT
Updated Date: Wed, 07 Oct 2020 00:00:00 EDT
Updated Date: Wed, 07 Oct 2020 00:00:00 EDT
